124.02 USD
▼-3.14-2.47%
盘后 123.00 -0.82%
2026-11-19
市值
$8.00B
市盈率
24.88
EPS
4.93
股息率
—
52 周区间
77.00 – 160.81
成交量
554.09K
Beta
1.22
目标价
182.36
52W 低 77.0052W 高 160.81
价格走势
公司简介
Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States. It develops Icotyde, a first-in-class investigational targeted oral peptide for the treatment of adults and pediatric patients 12 years of age and older with moderate-to-severe plaque psoriasis; and Rusfertide, a first-in-class investigational injectable mimetic of the natural hormone hepcidin in Phase 3 development for the treatment of the rare blood disorder polycythemia vera. The company is also developing PN-881, a potential best-in-class or...